Search

Your search keyword '"Piechnik, Stefan K."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Piechnik, Stefan K." Remove constraint Author: "Piechnik, Stefan K." Journal journal of cardiovascular magnetic resonance (biomed central) Remove constraint Journal: journal of cardiovascular magnetic resonance (biomed central)
37 results on '"Piechnik, Stefan K."'

Search Results

1. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.

2. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values.

3. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.

4. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - a clinical study using myocardial T1-mapping and extracellular volume quantification.

5. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.

6. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.

7. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1- mapping at 1.5 and 3 T within a 9 heartbeatbreathhold.

8. The diagnostic performance of novel techniques for the detection of acute myocarditis: a clinical study using cardiovascular magnetic resonance imaging.

9. T1-mapping accurately detects acute myocardial edema: a comparison to T2-weighted cardiovascular magnetic resonance imaging.

10. Single breath-hold Vd(m) calculation as good as multi breath-hold technique in Equilibrium Contrast CMR.

11. Age and gender dependence of pre-contrast T1-relaxation times in normal human myocardium at 1.5T using ShMOLLI.

12. The diagnostic performance of non-contrast T1-mapping in patients with acute myocarditis on cardiovascular magnetic resonance imaging.

13. Characterization of acute myocardial infarction by pre-contrast T1 mapping.

14. Histological validation of ShMOLLI equilibrium contrast CMR for the measurement of diffuse myocardial fibrosis.

15. Gaussian modelling for operator-independent and threshold-free volumetric segmentation of phase sensitive inversion recovery late gadolinium enhanced images.

16. Quantification of acute myocardial injury by ShMOLLI T1-Mapping, T2-weighted and late gadolinium imaging in patients presenting with chest pain, positive troponins and non-obstructive coronary arteries.

17. Quantification of acute myocardial injury in STEMI patients post revascularization at 3Tesla. Comparison of T1-mapping, late gadolinium and edema imaging.

18. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

19. Cardiovascular magnetic resonance reference values of mitral and tricuspid annular dimensions: the UK Biobank cohort.

20. Editorial Expression of Concern: Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.

21. Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects.

22. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort.

23. Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.

24. Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease.

25. Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.

26. Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias.

27. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.

28. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

29. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.

30. Right ventricular shape and function: cardiovascular magnetic resonance reference morphology and biventricular risk factor morphometrics in UK Biobank.

31. Automated quality control in image segmentation: application to the UK Biobank cardiovascular magnetic resonance imaging study.

32. Automated cardiovascular magnetic resonance image analysis with fully convolutional networks.

33. Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?

34. Impaired myocardial perfusion in moderate asymptomatic aortic stenosis relates to longitudinal strain but not non-contrast T1 values.

35. T1 mapping for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique.

36. Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis.

37. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveals a high burden of myocardial disease in HIV infection.

Catalog

Books, media, physical & digital resources